Thank you to all the participants who attended the webinar for the 2023 online individual assessment for classification of BRCA1, BRCA2 and other HRR gene variants (Run 10).
The webinar for run 10 of the Individual Variant Classification Assessment Scheme took place on the 23rd May 2023 where Dr. Simon Patton from EMQN, Professor Sandi Deans from GenQA (joint chairs) and an expert panel consisting of Trudi McDevitt (Dublin, Ireland), Andrew Muranyi (Alberta, Canada), and Maartje Vogel (Amsterdam, Netherlands) discussed details of the results of the Individual Competency Assessment in addition to a summary of participant performance. Please see the webinar below:
These assessments are open to all individuals who classify the pathogenicity of BRCA and HRR gene variants and provides assurance of their competency to achieve this accurately and in the most up-to-date manner.
If you have any further questions, please contact GenQA at info@genqa.org or EMQN at office@emqn.org.